Announcement on Voluntary Disclosure of Strategic Cooperation
Filed with SSE · · 3 pages · Chinese
Sinopep-Allsino Bio Pharmaceutical Co., Ltd. on 6ix
Earlier from Sinopep-Allsino Bio Pharmaceutical
- Announcement on Conversion Result of Convertible Bonds and Share Changes
- Announcement on Voluntary Disclosure of Performance Forecast in the First Quarter of 2025
- Indicative Announcement on "Sinopep-Allsino Convertible Bonds" Expected to Meet Redemption Conditions
- Announcement on Voluntary Disclosure of Subsidiary Passing the U.S. FDA On-site Inspection
- Announcement on Preliminary Earnings Estimate for 2024
Later from Sinopep-Allsino Bio Pharmaceutical
- Announcement on Implementing Redemption and Delisting of "Sinopep-Allsino Convertible Bonds"
- The 2nd Indicative Announcement on the Implementation of Redemption and Delisting of "Sinopep-Allsino Convertible Bonds"
- The 3rd Indicative Announcement on the Implementation of Redemption and Delisting of "Sinopep-Allsino Convertible Bonds"
- Special Report on Deposit and Use of Raised Funds in 2024
- The Last Indicative Announcement on the Implementation of Redemption and Delisting of "Sinopep-Allsino Convertible Bonds"
Follow Sinopep-Allsino Bio Pharmaceutical into a list and get an email when it puts out news.
Follow Sinopep-Allsino Bio Pharmaceutical